AVENTURA, Fla. – At its annual Self-Care Leadership Summit (SLS) this week, the Consumer Healthcare Products Association (CHPA) welcomed 19 new members since last year – five manufacturers and 14 associate members – reflecting the broadening landscape in personal healthcare including over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices. Additionally, the association and CHPA
NEW HOPE, Pa. – The Consumer Healthcare Products Association (CHPA) awarded its Ivan D. Combe Lifetime Achievement Award on Wednesday to longtime industry leader Scott Emerson. This annual award – the highest honor bestowed by the U.S. consumer healthcare industry – recognizes the outstanding work and contributions of individuals whose actions have created a lasting
WASHINGTON — The Consumer Healthcare Products Association (CHPA) released the following statement today following the House of Representative’s passage of H.R. 1996, the SAFE Banking Act: “CHPA commends the House of Representatives for its passage of H.R. 1996, the SAFE Banking Act, introduced by Representative Ed Perlmutter (D, Colo.). The legislation would ensure that financial
WASHINGTON – The Consumer Healthcare Products Association (CHPA), the national trade association representing leading manufacturers in the personal healthcare products industry, welcomes Church & Dwight, Bridges Consumer Healthcare, and Rhinomed as its newest manufacturer members of the association. The three companies play an important role in personal healthcare with product offerings that include over-the-counter (O-T-C)
WASHINGTON — The Consumer Healthcare Products Association (CHPA) has introduced the first Self-Care Leadership Series (virtual) that will culminate with a possible in-person summit on June 16 in New Hope, Pa. “We are excited to provide the kind of relevant and timely educational programming you have come to expect from CHPA in a new, virtual/live format that
WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced the election of two new members to the CHPA Board of Directors during the association’s virtual November meeting. Newly elected CHPA board members include: Tim Grannan, president, Blistex Inc. Don Kerrigan, president, North America, The Nature’s Bounty Co. Kerrigan was also elected to serve on the
WASHINGTON – The Consumer Healthcare Products Association (CHPA) will hold its 2020 Regulatory, Scientific & Quality (RSQ) Conference virtually, for the first time ever, Tuesday, September 1, through Thursday, September 3. Using a dynamic virtual platform, attendees will hear distinguished speakers from the U.S. Food and Drug Administration (FDA), the U.S. Federal Trade Commission (FTC), U.S. Pharmacopeia (USP), academia, and industry.
WASHINGTON — The Consumer Healthcare Products Association (CHPA) released the following statement in response to the U.S. Food and Drug Administration (FDA) report to Congress on the current cannabidiol (CBD) marketplace: “While CHPA welcomes additional input from FDA regarding CBD, we’re concerned that the report conclusion further delays any action to better regulate CBD-containing products.
WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced on Tuesday the appointment of Paul Gama as the new chair of the CHPA board of directors. Gama was elected on April 13, 2020, along with other new board members, at CHPA’s annual membership meeting conducted, for the first time ever, in a virtual forum online.
WASHINGTON — The Consumer Healthcare Products Association (CHPA) announced the appointment of Dr. John Troup as vice president for scientific affairs and dietary supplements, a brand-new position within CHPA. Dr. Troup has wide-ranging experience in the health, nutrition and dietary supplements sectors, including extensive work in clinical and product development, as well as regulatory affairs.
WASHINGTON — The United States Senate voted, 72-18, on Thursday to confirm Dr. Stephen Hahn as Commissioner of Food and Drugs. Health and Human Services Secretary Alex Azar issued the following statement: “I congratulate Dr. Hahn and thank the Senate for prioritizing his nomination. President Trump has chosen a superbly qualified leader for FDA, and
WASHINGTON — The Consumer Healthcare Products Association (CHPA) applauds Tuesday’s passage in the U.S. Senate of S. 2740, the Over-the-Counter Drug Safety, Innovation, and Reform Act by a vote of 91-2. “Thanks to today’s decisive Senate action, our nation is one step closer to having a modern over-the-counter (O-T-C) regulatory framework that will better serve
WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced that Beth Allgaier has been named senior vice president, business development and industry relations. Allgaier will be responsible for the association’s membership, education, and meetings functions, in addition to serving as chief liaison to the retail community. She will be a member of the association’s senior
WASHINGTON — The Consumer Healthcare Products Association (CHPA) submitted on Thursday a citizen petition to the U.S. Food and Drug Administration (FDA) urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol (CBD) in dietary supplements. “Intense consumer demand and commercial interest
